Skip to main contentSkip to navigation
Sirius Investors

NVS Stock: Novartis AG Stock Price, Analysis & Insights

Get live NVS stock price $148.12, comprehensive Novartis AG stock analysis, charts, news, and expert forecast. Real-time NVS stock data and investment insights.

148.12
0.67%Today
NVSNovartis AG • New York Stock Exchange • Healthcare
Market Cap
282.63B
Volume
1.43M
52W High
170.46
52W Low
112.34

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Novartis AG is a global healthcare enterprise dedicated to the discovery, development, production, and distribution of medical products across the world. The company operates through two main divisions: Innovative Medicines and Sandoz. Its Innovative...

Company Information

CEO
Vasant Narasimhan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
75883

Contact Information

Address
Lichtstrasse 35
Country
CH

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - General

Investment Highlights

Market leader with 282.6 billion market capitalization

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 21.2)

Lower volatility stock (Beta: 0.49) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Novartis AG shareholders
  • Market volatility can significantly impact stock price, especially for large-cap equities
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Novartis AG
  • Investors should consider how Novartis AG fits within their overall portfolio allocation

Market Cap

282.63B

P/E Ratio (TTM)

21.22

Beta

0.49

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

60/100 ⭐⭐⭐⭐

Overall
-1.4%
NYSE
-0.6%
NASDAQ
-2.2%
Sector1D1W1MP/EScore
Financial Services+0.2%+1.6%+1.7%19.1
100/100⭐⭐⭐⭐⭐
Communication Services-0.2%-1.8%+1.2%21.9
83/100⭐⭐⭐⭐⭐
Energy-0.2%-6.1%+1.5%37.0
75/100⭐⭐⭐⭐⭐
Healthcare-1.4%-3.7%-0.5%30.2
60/100⭐⭐⭐⭐
Technology-0.8%-7.7%+0.0%48.7
55/100⭐⭐⭐⭐
Consumer Defensive+0.7%+3.0%-1.6%31.1
50/100⭐⭐⭐
Real Estate-1.0%-1.8%-1.9%50.3
31/100⭐⭐
Industrials-2.7%-7.6%-2.1%41.5
30/100⭐⭐
Basic Materials-1.9%-6.0%-3.5%26.6
28/100⭐⭐
Utilities-2.1%-6.9%-8.5%25.3
24/100
Consumer Cyclical-1.5%-4.5%-3.4%52.2
14/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.